Labcorp Holdings Inc.

LH · NYSE · USD

Analyst consensus

Buy35 analysts

Bearish · 0 · Hold · 9 · Bullish · 26

Earnings history

	EPS	Estimate
Q3 2024	$3.50	$3.47	Beat
Q4 2024	$3.45	$3.39	Beat
Q1 2025	$3.84	$3.74	Beat
Q2 2025	$4.35	$4.17	Beat
Q3 2025	$4.18	$4.13	Beat
Q4 2025	$4.07	$3.95	Beat
Q1 2026	$4.25	$4.11	Beat
Q2 2026	$4.99	$4.78	Beat

Peers

Company overview

IPO dateMar 29, 1990

CEOAdam H. Schechter

Employees71,000

SectorHealthcare

IndustryMedical - Diagnostics & Research

CountryUS

ExchangeNew York Stock Exchange

Websitewww.labcorp.com

Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.

Athenic provides research and information tools for educational purposes only and is not a registered investment adviser or broker-dealer. Nothing on this page is investment advice or a recommendation to buy or sell any security. Market data may be delayed. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal.